Edmond de Rothschild Holding’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-188
| Closed | -$85.7K | – | 565 |
|
|
2025
Q3 | $85.7K | Hold |
188
| – | – | ﹤0.01% | 436 |
|
|
2025
Q2 | $61.3K | Sell |
188
-130
| -41% | -$36K | ﹤0.01% | 440 |
|
|
2025
Q1 | $85.9K | Buy |
318
+49
| +18% | +$12.6K | ﹤0.01% | 426 |
|
|
2024
Q4 | $63.3K | Buy |
+269
| New | +$70.7K | ﹤0.01% | 482 |
|
|
2024
Q3 | – | Sell |
-53,050
| Closed | -$12.9M | – | 631 |
|
|
2024
Q2 | $12.9M | Sell |
53,050
-12,000
| -18% | -$1.89M | 0.22% | 106 |
|
|
2024
Q1 | $9.72M | Buy |
65,050
+49,250
| +312% | +$8.22M | 0.16% | 128 |
|
|
2023
Q4 | $3.02M | Buy |
+15,800
| New | +$2.69M | 0.05% | 202 |
|
|
2018
Q4 | – | Sell |
-208
| Closed | -$18K | – | 677 |
|
|
2018
Q3 | $18K | Hold |
208
| – | – | ﹤0.01% | 679 |
|
|
2018
Q2 | $20K | Hold |
208
| – | – | ﹤0.01% | 676 |
|
|
2018
Q1 | $25K | Hold |
208
| – | – | ﹤0.01% | 688 |
|
|
2017
Q4 | $26K | Hold |
208
| – | – | ﹤0.01% | 693 |
|
|
2017
Q3 | $24K | Hold |
208
| – | – | ﹤0.01% | 718 |
|
|
2017
Q2 | $17K | Hold |
208
| – | – | ﹤0.01% | 739 |
|
|
2017
Q1 | $11K | Hold |
208
| – | – | ﹤0.01% | 773 |
|
|
2016
Q4 | $8K | Hold |
208
| – | – | ﹤0.01% | 773 |
|
|
2016
Q3 | $14K | Hold |
208
| – | – | ﹤0.01% | 771 |
|
|
2016
Q2 | $12K | Hold |
208
| – | – | ﹤0.01% | 751 |
|
|
2016
Q1 | $13K | Hold |
208
| – | – | ﹤0.01% | 744 |
|
|
2015
Q4 | $20K | Hold |
208
| – | – | ﹤0.01% | 716 |
|
|
2015
Q3 | $17K | Hold |
208
| – | – | ﹤0.01% | 731 |
|
|
2015
Q2 | $25K | Buy |
+208
| New | +$24.9K | ﹤0.01% | 707 |
|
Other funds holding ALNY
